Evidence map›Paper›PMID 28498894›Full record

ReviewThe journals of gerontology. Series A, Biological sciences and medical sciences2017

The Intersection of Aging Biology and the Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop.

G R Scott Budinger, Ronald A Kohanski, Weiniu Gan, Michael S Kobor, Luis A Amaral, Mary Armanios, Karl T Kelsey, Annie Pardo, Rubin Tuder, Fernando Macian and 18 more

Open access · bronzeAbstract readReview
In one paragraph

Review in The journals of gerontology. Series A, Biological sciences and medical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cell Proliferation and Apoptosis-Key Players in the Lung Aging Process.International journal of molecular sciences · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 13 institutions in 3 countries.

G R Scott BudingerFeinberg School of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, Illinois.
Ronald A KohanskiDivision of Aging Biology, National Institute on Aging, National Institutes of Health, Bethesda, Maryland.
Weiniu GanDivision of Lung Diseases, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Michael S KoborCenter for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.
Luis A AmaralDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois.
Mary ArmaniosDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Karl T KelseyDepartments of Epidemiology, Laboratory Medicine & Pathology, Brown University, Providence, Rhode Island.
Annie PardoInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Tlalpan, México.
Rubin TuderDepartment of Medicine, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado at Denver Health Sciences Center, Denver, Colorado.
Fernando MacianDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.
Navdeep ChandelFeinberg School of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, Illinois.
Douglas VaughanFeinberg School of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, Illinois.
Mauricio RojasDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Ana L MoraDivision of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Elizabeth KovacsDepartment of Surgery, University of Colorado at Denver Health Sciences Center, Denver, Colorado.
Steven R DuncanUniversity of Alabama at Birmingham, Birmingham, Alabama.
Toren FinkelCenter for Molecular Medicine, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Augustine ChoiWeill Cornell Medical College, Division of Pulmonary and Critical Care Medicine, Weill Department of Medicine, New York, New York.
Oliver EickelbergPulmonary Sciences and Critical Care Medicine, University of Colorado, Anschutz Medical Campus.
Danica ChenProgram in Metabolic Biology, Nutritional Sciences & Toxicology, University of California, Berkeley, California.
Alvar AgustiRespiratory Institute, Hospital Clinic, IDIBAPS, University of Barcelona, CIBERES, Spain.
Moises SelmanInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Tlalpan, México.
William E BalchDepartment of Chemical Physiology, Department of Cell and Molecular Biology, The Skaggs Institute of Chemical Biology, The Scripps Research Institute, La Jolla, California.
Paula BusseDivision of Clinical Immunology, Department of Medicine, Mount Sinai School of Medicine, New York, New York.
Anning LinBen May Department for Cancer Research, University of Chicago, Chicago, Illinois.
Richard MorimotoDepartment of Molecular Biosciences, Rice Institute for Biomedical Research, Northwestern University, Evanston, Illinois.
Jacob I SznajderFeinberg School of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, Illinois.
Victor J ThannickalUniversity of Alabama at Birmingham, Birmingham, Alabama.
University of Alabama at Birmingham · USUniversity of Pittsburgh · USAlbert Einstein College of Medicine · USConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESIcahn School of Medicine at Mount Sinai · USJohns Hopkins Medicine · USNational Heart Lung and Blood Institute · USNational Institute on Aging · USNational Institutes of Health · USNorthwestern University · USRice Institute · USUniversity of British Columbia · CAUniversity of Chicago · US

Funding

VARIABILITY, STABILITY & SMOOTHNESS OF WALKINGP30AG024827 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JENNIFER S BRACH · 2004 to 2026
$28.6M
Tissue resident macrophages regulate proteostasis in the aging lungP01AG049665 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Benjamin David Singer · 2015 to 2026
$26.9M
The role of autophagy in aging and metabolismZIAHL005012 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI FINKEL, TOREN · 2009 to 2017
$11.8M
Restoration of mutant CFTR stability and functionR01DK051870 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BALCH, WILLIAM EDWARD · 1996 to 2020
$8.7M
Aging of Mesenchymal Stem Cells Missing Link in IPFR01HL123766 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ROJAS, MAURICIO · 2015 to 2018
$1.9M
Signaling mechanisms by which mitochondria regulates fibrosis in the lungR01HL131789 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MORA, ANA LUCIA · 2016 to 2019
$1.7M
Myofibroblast Senescence in Pulmonary FibrosisR01AG046210 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI THANNICKAL, VICTOR J. · 2014 to 2018
$1.6M
Nutrient Sensing and the Oxidative Stress ResponseR01AG040990 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHEN, DANICA · 2011 to 2015
$1.5M
Obesity and HematopoiesisR01DK101885 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHEN, DANICA · 2015 to 2017
$942k
Sirtuins in Lung Aging and FibrosisI01BX003056 · VA · SOUTHEAST LOUISIANA VETERANS HEALTH CARE · PI THANNICKAL, VICTOR J. · 2016 to 2025
–
BLRD VA I01 BX003056NHLBI NIH HHS R01 HL123766NHLBI NIH HHS R01 HL131789NIA NIH HHS P01 AG049665NIA NIH HHS P30 AG024827NIA NIH HHS R01 AG040990NIA NIH HHS R01 AG046210NIDDK NIH HHS R01 DK051870NIDDK NIH HHS R01 DK101885
6 · The paper itself

Abstract

Death from chronic lung disease is increasing and chronic obstructive pulmonary disease has become the third leading cause of death in the United States in the past decade. Both chronic and acute lung diseases disproportionately affect elderly individuals, making it likely that these diseases will become more frequent and severe as the worldwide population ages. Chronic lung diseases are associated with substantial morbidity, frequently resulting in exercise limiting dyspnea, immobilization, and isolation. Therefore, effective strategies to prevent or treat lung disease are likely to increase healthspan as well as life span. This review summarizes the findings of a joint workshop sponsored by the NIA and NHLBI that brought together investigators focused on aging and lung biology. These investigators encouraged the use of genetic systems and aged animals in the study of lung disease and the development of integrative systems-based platforms that can dynamically incorporate data sets that describe the genomics, transcriptomics, epigenomics, metabolomics, and proteomics of the aging lung in health and disease. Further research was recommended to integrate benchmark biological hallmarks of aging in the lung with the pathobiology of acute and chronic lung diseases with divergent pathologies for which advanced age is the most important risk factor.

Indexed as

AgingHumansLung DiseasesMetabolomicsNational Heart, Lung, and Blood Institute (U.S.)United StatesAge-related pathologyBiology of agingLungs/pulmonary

Identifiers

PMID28498894
PMCPMC5861849
OpenAlexW2612986562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.